?帕妥珠单抗
背景:帕妥珠单抗(Perjeta),是一种重组单克隆抗体,由罗氏旗下基因泰克公司生产。
?帕妥珠单抗注射剂
) 【英文名】Perjeta(pertuzumab) 【中文名】帕妥珠单抗注射剂 【适应证和用途】PERJETA是一种HER2/neu受体拮抗剂，应与曲妥单抗[trastuzumab]和多西他赛[docetaxel]联用，人群为：既往未曾接
?乳腺癌
Perjeta（乳腺癌）罗氏 罗氏一直是乳腺癌治疗领域的龙头企业，公司开发的Perjeta和赫赛汀一直是HER-2阳性乳腺癌临床治疗的经典药物。
Perjeta is a genetically engineered molecule that targets the HER-2 protein, the same protein targeted by the drug Herceptin.
FORBES: Exciting New Breast Cancer Drug Poised to Break the Bank?
While Roche has already launched one of the potential blockbuster, Perjeta, in several markets, it has also filed approval applications for T-DM1.
FORBES: Roche's Worth $58 On Continued Growth And Strong Pipeline
Suppose in a best case scenario that the six month delay in progression caused by Perjeta leads to a six month delay in death.
英汉双解词典包含3185865条英汉词条，基本涵盖了全部常用单词的翻译及用法，是英语学习的有利工具。